Varietal Counting Of Nucleic Acids For Obtaining Genomic Copy Number Information

Patent No. US10947589 (titled "Varietal Counting Of Nucleic Acids For Obtaining Genomic Copy Number Information") was filed by James Hicks on Mar 7, 2016.

What is this patent about?

’589 is related to the field of genomic analysis , specifically methods for determining the copy number of DNA or RNA sequences in a sample. Traditional methods like whole genome amplification (WGA) introduce biases due to non-uniform amplification, leading to inaccurate copy number estimations. This is particularly problematic when analyzing small amounts of DNA, such as from single cells, where stochastic effects are amplified.

The underlying idea behind ’589 is to tag individual nucleic acid molecules with unique identifiers (tags) before amplification. By counting the number of unique tags associated with a particular genomic location after amplification and sequencing, the original copy number can be accurately determined, minimizing the impact of amplification bias. This approach essentially converts sequencing into a counting method, where each unique tag represents a single original molecule.

The claims of ’589 focus on a method comprising obtaining segments of genomic nucleic acids, tagging these segments with unique nucleic acid tags, amplifying the tagged molecules using PCR, sequencing the amplified products to generate tag-associated sequence reads, mapping these reads to a reference genome, and then counting the number of unique tags assigned to each location on the genome. This process allows for the determination of genomic copy number information that is less susceptible to amplification distortion.

In practice, the method involves fragmenting genomic DNA or cDNA, attaching unique tags to these fragments, and then amplifying the tagged fragments using PCR. The resulting amplified DNA is then sequenced using high-throughput sequencing technologies. The sequence reads are mapped back to a reference genome or cDNA library, and the number of unique tags associated with each genomic location is counted. This count provides an estimate of the original copy number of that region, effectively correcting for any amplification biases introduced during PCR.

This approach differs from prior methods that rely on uniform amplification of the entire genome. By tagging individual molecules before amplification, ’589 allows for accurate copy number determination even when amplification is non-uniform. The use of unique tags enables the differentiation of PCR duplicates from truly independent molecules, providing a more accurate representation of the original sample's genomic content. This is particularly useful for analyzing single cells or other samples with limited amounts of DNA or RNA.

How does this patent fit in bigger picture?

Technical landscape at the time

In the early 2010s when ’589 was filed, obtaining genomic copy number information at a time when whole genome amplification (WGA) was typically used. However, WGA methods often resulted in non-uniform amplification of the genome. Therefore, hardware or software constraints made obtaining genomic copy number information unaffected by amplification distortion non-trivial.

Novelty and Inventive Step

The examiner approved the application because claims 88-103 and 105-107 were allowable given the applicant's amendments filed on November 25, 2020, the terminal disclaimer filed on April 17, 2019, and the examiner's amendment. Rejections under 35 U.S.C 101 and 112 (b) were withdrawn. The examiner stated that no prior art, either alone or in combination, taught or suggested a method comprising all limitations recited in claims 88 and 94.

Claims

This patent contains 19 claims, with independent claims 1 and 19. Independent claim 1 focuses on a method for obtaining copy number information from genomic nucleic acids by tagging and sequencing segments, while independent claim 19 focuses on a method for obtaining a count for each location on a cDNA library by generating and sequencing tagged nucleic acid molecules from mRNA transcripts. The dependent claims generally elaborate on and refine the methods described in the independent claims, adding steps, specifying conditions, or providing further details.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
First order derivative strands
(Claim 19)
“Also provided is a method for obtaining from mRNA transcripts mRNA copy number information unaffected by amplification distortion, comprising: a) generating tagged nucleic acid molecules, comprising: i) subjecting the mRNA transcripts to a polymerase reaction in the presence of primers capable of hybridizing to the polyA tail of the mRNA transcripts under conditions that promote the formation of only one complement, thereby generating first order derivative strands;”Complementary DNA strands generated from mRNA transcripts using a polymerase reaction and primers that hybridize to the polyA tail of the mRNA.
Nucleic acid tags
(Claim 1, Claim 19)
“A method is provided for obtaining from genomic material genomic copy number information unaffected by amplification distortion, comprising: b) tagging the segments with substantially unique tags to generate tagged nucleic acid molecules, such that each tagged nucleic acid molecule comprises one segment of the genomic material from step (a) and a tag;”Short sequences of nucleotides used to uniquely label segments of genomic nucleic acids or mRNA transcripts.
Second order derivative strands
(Claim 19)
“Also provided is a method for obtaining from mRNA transcripts mRNA copy number information unaffected by amplification distortion, comprising: a) generating tagged nucleic acid molecules, comprising: iii) subjecting the first order derivative strands to a polymerase reaction in the presence of primers capable of hybridizing to the polynucleotide tail added in step (ii) under conditions that promote the formation of only one complement, thereby generating second order derivative strands”Complementary DNA strands generated from the first order derivative strands using a polymerase reaction and primers that hybridize to a polynucleotide tail added to the first order derivative strands.
Tag associated sequence reads
(Claim 1, Claim 19)
“A method is provided for obtaining from genomic material genomic copy number information unaffected by amplification distortion, comprising: d) generating tag associated sequence reads by sequencing the product of step (c);”Sequences generated by sequencing the amplified tagged nucleic acid molecules, where each read contains both the tag sequence and a sequence derived from the original nucleic acid segment.
Unique tagged nucleic acid molecules
(Claim 1, Claim 19)
“A method is provided for obtaining from genomic material genomic copy number information unaffected by amplification distortion, comprising: b) tagging the segments with substantially unique tags to generate tagged nucleic acid molecules, such that each tagged nucleic acid molecule comprises one segment of the genomic material from step (a) and a tag;”Nucleic acid molecules, each comprising a segment of genomic nucleic acid or mRNA transcript and a unique nucleic acid tag, such that each molecule is distinguishable from others based on its tag.

Litigation Cases New

US Latest litigation cases involving this patent.

Case NumberFiling DateTitle
1:25-cv-00263Mar 6, 2025Cold Spring Harbor Laboratory V. Guardant Health, Inc.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents

US10947589

JAMES HICKS
Application Number
US15063278
Filing Date
Mar 7, 2016
Status
Granted
Expiry Date
Dec 5, 2031
External Links
Slate, USPTO, Google Patents